Detalhe da pesquisa
1.
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
J Card Fail
; 28(3): 370-384, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793971
2.
Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction.
J Card Fail
; 28(2): 191-201, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34428591
3.
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.
Am Heart J
; 235: 82-96, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497697
4.
Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry.
Am Heart J
; 189: 177-183, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28625374
5.
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.
J Am Heart Assoc
; : e022889, 2022 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35722989
6.
Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model.
ESC Heart Fail
; 9(1): 178-185, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791838
7.
The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF.
Eur J Heart Fail
; 24(5): 762-770, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293088
8.
Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
JACC Heart Fail
; 9(1): 28-38, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309579
9.
Association between sacubitril/valsartan initiation and real-world health status trajectories over 18 months in heart failure with reduced ejection fraction.
ESC Heart Fail
; 8(4): 2670-2678, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932120
10.
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.
JAMA Cardiol
; 6(5): 522-531, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760037
11.
Diuretic Changes, Health Care Resource Utilization, and Clinical Outcomes for Heart Failure With Reduced Ejection Fraction: From the Change the Management of Patients With Heart Failure Registry.
Circ Heart Fail
; 14(11): e008351, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674536
12.
Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF.
Circ Heart Fail
; 13(7): e006833, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580657
13.
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
JACC Heart Fail
; 8(6): 469-480, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32387066
14.
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF).
Am J Cardiol
; 124(12): 1900-1906, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679641
15.
Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure With Reduced Ejection Fraction.
JACC Heart Fail
; 7(11): 933-941, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31521679
16.
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.
J Am Coll Cardiol
; 73(19): 2365-2383, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30844480
17.
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.
JACC Heart Fail
; 7(7): 615-625, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176672
18.
Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.
JACC Heart Fail
; 7(4): 350-358, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30738978
19.
Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial.
J Am Heart Assoc
; 7(12)2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895587
20.
Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States.
Circ Heart Fail
; 11(9): e005400, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30354360